Page last updated: 2024-10-26

ethosuximide and Diffuse Myofascial Pain Syndrome

ethosuximide has been researched along with Diffuse Myofascial Pain Syndrome in 1 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Research Excerpts

ExcerptRelevanceReference
"In a mouse model of reserpine induced fibromyalgia, the effect of ethosuximide, sodium butyrate, and pregabalin was investigated."8.31The immunomodulatory effects of ethosuximide and sodium butyrate on experimentally induced fibromyalgia: The interaction between IL-4, synaptophysin, and TGF-β1/NF-κB signaling. ( Abd Elmaaboud, MA; Awad, MM; El-Shaer, RAA; Kabel, AM, 2023)
"In a mouse model of reserpine induced fibromyalgia, the effect of ethosuximide, sodium butyrate, and pregabalin was investigated."4.31The immunomodulatory effects of ethosuximide and sodium butyrate on experimentally induced fibromyalgia: The interaction between IL-4, synaptophysin, and TGF-β1/NF-κB signaling. ( Abd Elmaaboud, MA; Awad, MM; El-Shaer, RAA; Kabel, AM, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abd Elmaaboud, MA1
Awad, MM1
El-Shaer, RAA1
Kabel, AM1

Other Studies

1 other study available for ethosuximide and Diffuse Myofascial Pain Syndrome

ArticleYear
The immunomodulatory effects of ethosuximide and sodium butyrate on experimentally induced fibromyalgia: The interaction between IL-4, synaptophysin, and TGF-β1/NF-κB signaling.
    International immunopharmacology, 2023, Volume: 118

    Topics: Animals; Butyric Acid; Dopamine; Ethosuximide; Fibromyalgia; Glutamates; Interleukin-4; Mice; NF-kap

2023